National Plan Cancer Control

Cancer National Control Plan 2014
Saudi Arabia English PDF
National

AI-Generated Document Summary

Objectives

Establish a comprehensive national cancer control programme to protect Saudi society from cancer through shared responsibility, evidence-based prevention, early detection, integrated treatment and palliative care across primary, secondary and tertiary services.The programme responds to cancer’s substantial health, social, developmental and financial burden, recognising that behavioural and environmental factors account for an estimated 80–90% of cases and that at least 30% may be preventable through integrated interventions.

  • Prevent cancer through tobacco control, healthier diets, physical activity, obesity reduction, protection from environmental and occupational carcinogens, reduced excessive sun exposure, and prevention of infection-related cancers.
  • Detect breast, cervical, colorectal, oral and skin cancers at early and treatable stages, using early diagnosis and screening alongside effective referral and treatment.
  • Improve cancer-service quality by strengthening diagnosis, treatment, rehabilitation, palliative care, home care and multidisciplinary support, while standardising treatment regimens and clinical guidance.
  • Strengthen cancer surveillance, monitoring and evaluation through improved national and Gulf cancer registries, quality standards, stage data and survival analysis.
  • Conduct epidemiological, clinical and economic research to guide evidence-based planning and elevate cancer control among decision-makers in Gulf Cooperation Council countries.
  • Involve patients, families, civil society, government institutions and the private sector in care, quality control and community partnership.

Key quantified ambitions include detecting priority tumours early within five years and reducing mortality from these tumours by about 20% within ten years.Primary-prevention ambitions include reducing adult tobacco use by 5% over ten years, reducing overweight and obesity by at least 10%, increasing physical activity by at least 20%, and doubling the proportion of ex-smokers within ten years.Breast-cancer objectives prioritise treatable and curable disease, with long-term mortality reductions of 25–30% for women aged 50–69 and 15% for women aged 40–49.

Implementation

Implement the programme through national coordination, cross-sectoral prevention, integrated service delivery, workforce development, standardised protocols, referral systems, information systems and periodic performance review.The approach requires government commitment, prioritisation and resource allocation, while engaging Ministry of Health departments, specialist cancer centres, hospitals, primary care centres, universities, non-governmental organisations, relevant government bodies, private-sector actors and health decision-makers.

  • Establish a Supreme National Cancer Control Committee, with a chair, members and sub-committees, supported by administrative, financial, technical and technical-assistance arrangements.
  • Coordinate health sectors, ministries, legislative bodies and non-governmental organisations; include high-level non-governmental organisation representation on the national cancer committee; and deliver joint community programmes.
  • Prepare central and regional oncology and early-detection clinics, well-being clinics in primary care, cancer units in referral hospitals and specialised third-level treatment centres.
  • Establish clinic procedures, referral and case-transfer mechanisms, feedback arrangements and multidisciplinary teams, linking primary, secondary and specialist care.
  • Deliver a mammography-based breast-cancer early-detection programme for women aged 40–65, supported by registers, a central diagnostic clinic, regional sub-clinics, specialist teams and training for primary-care workers and volunteers.
  • Develop and update evidence-based clinical, nutritional, tumour-treatment and palliative-care guidance, alongside ethics committees for cancer research and treatment.
  • Provide palliative care from early in illness, addressing pain and physical, psychological and spiritual needs, supporting patients and families, and combining hospital services with home care where appropriate.
  • Strengthen workforce and public capability through training for health professionals, caregivers, volunteers and communities; educational materials; media and field campaigns; school curricula; workshops; conferences; and a programme website.
  • Use legislation, food labelling, healthy school and workplace meals, urban planning, safe walking and cycling routes, worker-protection measures and hazardous-substance controls to reduce population risk.
  • Integrate infant hepatitis B vaccination into the national expanded vaccination programme and assess human papillomavirus prevalence among women aged 20–25 to inform vaccination considerations.

Monitoring combines baseline surveys, routine data systems, cancer registries, data-quality checks and annual performance assessment.Indicators include registration completeness and accuracy, survival for common cancers, service-quality measures, research completion, patient satisfaction, participation in care, home-care delivery and joint community activities.Breast-screening monitoring covers mammography coverage, response, stage distribution, referral, treatment and mortality, with a target of 75% coverage every three years and a goal to reduce stage 3 and 4 diagnoses to 20%.

Financial governance includes budget allocation for the main programme and sub-programmes, identification of funding sources, charitable contributions, financial rules and resource allocation.Government financial support is envisaged for palliative-care integration and service resources, and approved cancer research studies require budget monitoring.No quantified overall budget, funding allocation, funding gap or cost-effectiveness analysis is specified.

Monitoring & Evaluation

The plan establishes a broad monitoring and evaluation agenda centred on cancer surveillance, early detection, service quality, prevention outcomes, research performance and community participation. It calls for strengthened national and Gulf cancer registries, routine institutional data collection, data-quality checks, survival analysis and a comprehensive database for programme evaluation.It also requires periodic programme evaluation, weekly and monthly supervision and follow-up timetables, and annual assessment of cancer-control performance.

  • Strengthen cancer registry completeness, accuracy, stage reporting and survival data for common cancers.
  • Assess routinely obtainable institutional indicators, registration completeness, data accuracy, survival rates and adherence to defined quality and performance standards.
  • Evaluate early-detection and prevention programmes, including diagnosis, referral, treatment and follow-up of detected cases.
  • Conduct baseline and follow-up surveys on cancer stage, target populations, dietary practices, viral hepatitis, human papillomavirus prevalence, and environmental, food-related and occupational carcinogens.

Early detection is monitored through tumour-specific coverage, diagnostic and treatment measures. For breast cancer, the plan proposes monitoring mammography coverage, screening response, early detection, stage distribution, referral and treatment after abnormal mammograms, and mortality.It targets 75% mammography coverage of the target group every three years, reduction of stage 3 and 4 diagnoses to 20%, specialist diagnosis and urgent treatment for all women with abnormal mammograms, reduction of advanced disease at diagnosis to 10%, and mortality reduction of at least 25% after ten years.Elsewhere, the plan seeks early detection of breast, cervical, colorectal, oral and skin cancers within five years and approximately 20% lower mortality from these tumours within ten years.

Prevention monitoring covers tobacco, diet, physical activity, obesity, infections and carcinogenic exposures. Indicators include adult tobacco use and tobacco use among 13 to 15-year-olds through the Global Youth Tobacco Survey, overweight and obesity, central obesity, physical activity, fruit and vegetable consumption, tobacco-free indoor places, cancer-causing infections, and environmental and occupational exposures.The plan defines overweight as a body mass index of 25 to 29.9 kg/m² and obesity as a body mass index of at least 30 kg/m².It also specifies waist-to-hip ratio thresholds of 0.85 for men and 0.95 for women, and waist-circumference thresholds of 94 cm for men and 80 cm for women.

  • Track a 5% reduction in adult tobacco use over ten years, a 10% increase in ex-smokers over ten years, at least a 10% reduction in overweight and obesity, and at least a 20% increase in physical activity.
  • Monitor occupational carcinogen exposure against thresholds set by the qualified national authority and organise occupational-health surveillance where necessary, while recognising that its effectiveness is unproven for most occupational cancers.
  • Assess human papillomavirus prevalence among women aged 20 to 25 and repeat surveys at approximately five-year intervals where low prevalence is found.
  • Measure awareness before and after education programmes, awareness campaigns, schools including cancer content, school physical-activity provision, walking tracks and parks per population, healthy school canteens, nutrition education and practitioner training.
  • Evaluate risk-factor legislation through the number of enacted measures, commitment to the World Health Organization Framework Convention on Tobacco Control and compliance with relevant laws.

Service-quality monitoring includes the proportion of patients seen in primary care, specialist staffing against international rates, annual training coverage, availability of evidence-based guidance, cancer units and specialised centres, and alignment of services with relevant guidance.Palliative-care planning includes assessing the number of people needing care using cancer deaths, identifying patient and family needs and service gaps, establishing standards, and evaluating implemented activities.The plan also measures patient satisfaction, patient and family involvement in treatment control, education and home-care programmes, community-care nurses, social workers, patient adherence, completed research studies, and joint programmes involving community institutions.

Accountability mechanisms include a Supreme National Cancer Control Committee, programme supervision, financial oversight, resource allocation, periodic evaluation and coordination across implementing agencies.However, the available text does not specify a consolidated reporting schedule, named data custodians, audit procedures, formal accountability sanctions or a complete indicator framework with targets for every area.

Costing & Financing

Financing provisions are largely institutional rather than quantified. The administrative programme is expected to allocate budgets for the main programme and sub-programmes, identify funding sources, address charitable contributions, establish financial rules, supervise financial matters and allocate resources.Government financial support is also envisaged for integrating palliative care into the national health system and securing the resources required for palliative services.

  • Monitor budgets for implementation of approved epidemiological, clinical and economic cancer research studies.
  • Support resource requirements for service delivery, including early-detection clinics, specialised teams, referral systems, training, cancer registries, information systems, palliative care, essential pain medicines and home care.
  • Recognise cancer as imposing a financial burden greater than that of other diseases, with adverse social and economic consequences for community development.

No numeric budget, expenditure ceiling, unit cost, funding allocation, financing source, resource-mobilisation target, funding gap, cost-effectiveness analysis or other economic assumption is specified in the available text.

Document Viewer